Product Information

CORLANOR 5 MG TABLET is a brand product labeled by Amgen Inc., priced at $10.0089 per EA under NDC 55513080060. Its NADAC has been published 562 times since Nov 18, 2015.

FDA first approved this application on Apr 15, 2015.

The High Outlier badge above means this manufacturer's average price in the ivabradine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

CORLANOR 5 MG TABLET

ivabradine
$10.0089per EA
High Outlier

Strength

5 mg/1

Manufacturer

Amgen Inc.

NDC

55513080060

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

IVABRADINE HYDROCHLORIDE

Approval Type

New Drug (NDA)

FDA Application

NDA206143

FDA Approved

4/15/2015

On Market Since

4/20/2015

Pharmacological Classes

Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists
Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker

Price Statistics

The NADAC for CORLANOR 5 MG TABLET has been published 562 times since Nov 18, 2015, and over the history we have for it it has risen 66.4%. The table below summarizes its recorded NADAC range and movement.

Current price$10.0089 per EA
All-time high$10.0089 (Aug 19, 2026)
All-time low$5.8725 (Dec 23, 2015)
52-week high$10.0089
52-week low$9.9742
Median price$7.8273
Average price$8.0300
Largest weekly change+5.9% (Feb 3, 2021)
Weeks tracked562
Tracking sinceNov 18, 2015

Price History

1W

+0.1%

1M

+0.1%

3M

+0.2%

6M

+0.3%

1Y

+0.2%

3Y

+9.4%

5Y

+27.9%

All

+66.4%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 92% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 92%

1 alternative • Same active ingredient

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of CORLANOR 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CORLANOR 5 MG TABLET, manufactured by Amgen Inc., is $10.0089 per EA (NDC 55513080060), effective Aug 19, 2026.

How has the price of CORLANOR 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for CORLANOR 5 MG TABLET has risen 66.4%. It has been tracked across 562 weekly CMS publications since Nov 18, 2015.

What are the highest and lowest recorded NADAC prices for CORLANOR 5 MG TABLET?

Since Nov 18, 2015, the NADAC for CORLANOR 5 MG TABLET has ranged from a low of $5.8725 (Dec 23, 2015) to a high of $10.0089 (Aug 19, 2026), with a median of $7.8273 per EA.

Are there cheaper alternatives to CORLANOR 5 MG TABLET?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IVABRADINE HCL 5 MG TABLET, is $0.7645 per EA — about 92% below CORLANOR 5 MG TABLET.

Who manufactures CORLANOR 5 MG TABLET?

CORLANOR 5 MG TABLET (NDC 55513080060) is labeled by Amgen Inc., and CMS classifies it as a brand product.